Association for Scientific Pursuits in Innovative Research Enterprises (ASPIRE), is a Not-for-Profit Section 8 Company founded by the University of Hyderabad in 2018 to foster an entrepreneurial ecosystem on the campus. ASPIRE provides an enabling resource platform for budding entrepreneurs in diverse areas of science and technology. Currently, three incubation centers (ICs) are functioning under ASPIRE, i.e., ASPIRE-BioNEST, ASPIRE-TBI, and ASPIRE TIDE, providing incubation support in the areas of Life Sciences, Pharma & Chemistry, Materials, and IT & Electronics. It is the largest incubation ecosystem for sciences in Hyderabad. ASPIRE supported over 85 start-ups to translate their ideas into technologies. ASPIRE is celebrating its 5th Foundation day.
ASPIRE-BioNEST in Association with IKP Knowledge Park is Organizing an Outreach Session on Biotechnology Industry Research Assistance Council (BIRAC) Ignition Grant (BIG) Entrepreneurship Opportunities on 30th Jan 2023.
With a view to promoting entrepreneurial activity among academic institutions, ASPIRE in association with the DST Technology Enabling Centre at the University of Hyderabadis organizing a two-day conference on “Building Entrepreneurial Ecosystem in Universities – Opportunities and Challenges” with a focus on Life Sciences, Chemistry, and IT & Electronics. We are pleased to invite you to participate in this brainstorming event. There is no registration fee to attend this physical event but registration is a must.
An ASPIRE-BioNEST Startup ReaGene Innovations was presented best Research Award at the Advances in Molecular Diagnostics and Precision Medicine International Conference in Chennai from 15 – 17 September 2022.
The award was in recognition of their work on designing 3D bioprinted human models of COVID-19 and Type 2 Diabetes which the Company used to launch therapeutics in less than 2 years. 3D bioprinting is a cutting-edge technology which allows scientists to create human-like organs for discovery and development of drugs against human diseases. The presentation was made by the Companies’ young scientific team of Arpitha Reddy R.N, Sanjana Battula and Saranya K with contribution from Kranti Meher.
Dr. Uday Saxena, Co-Founder and CEO of Reagene Innovations said that the use of 3D bioprinting of human like organs and disease systems can save the pharma industry time, several millions of dollars and increase likelihood of success in launching new products. Dr. Subrahmanyam Vangala, Co-Founder of Reagene Innovations, added that this is breakthrough technology which was much needed in an industry where failure rates are high. Dr. Satish Chandran, CEO of Lay Sciences, USA, the Company’s business partner, said that bringing new products rapidly to the patient’s using 3D technologies is the beginning of a new paradigm in the healthcare industry.
ReaGene Innovations and its Science and Business partners, Lay Sciences USA, Prodigy Bio, USA and Kyntox Bio, Bengaluru plan to collaborate extensively to bring forward several new product launches using similar innovative and proprietary discovery platforms.
Stem cell therapy is considered the latest innovation in Medicine and holds a lot of promise. It has the potential to treat many ailments that have poor treatment options. This talk will examine the salient clinical trials that show the efficacy and safety of stem cell therapy. Additionally, the mechanism of action of stem cells will be discussed.
About the Speaker :
Dr. Sairam Atluri is a pioneer of stem cell therapy in the US. He published the first ever controlled trial using stem cells to treat severe low back pain. Also has written highly cited, review articles regarding treating Covid-19 with stem cells. Dr. Atluri is the Co-Editor of the largest textbook regarding Regenerative Medicine in Pain Management. He was also part of the team which wrote guidelines for the treatment of low back pain with stem cells. He is a regular speaker at the annual meetings of ASIPP, TOBI, and IOF which are the premier stem cell organizations in the US.
Organized by ASPIRE-BioNESTin association with School of Life Sciences, UoH